Lupin has acquired the worldwide rights for Australian brand Goanna from Aspen Pharmacare Holdings for an undisclosed amount. The acquisition has been carried out by its Australian arm, Generic Health Pty Ltd under which it will get the rights to the entire range of products under the Goanna brand, including premium therapeutic oils, rubs and ointments.
The company’s sales and marketing efforts will commence immediately since Goanna is an in-market commercial product. Goanna brand has been used by generations of Australians to provide effective relief from muscular aches and pains and other conditions such as arthritis. The company intends to add a number of brand extensions to the range that will further reinforce the position of the range of products in the Australian market. The brand is being sold by about 83 per cent pharmacies in Australia, which would also go a long way in increasing the companies’ reach in the market.
Aspen Pharmacare Holdings is the largest listed pharma company in South Africa with market capitalisation of USD 5.9 billion. crackcrack
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: